Bormioli Pharma has become a member of Glass Futures, a UK-based not-for-profit company operating to reduce the environmental impact of glass production, through research into new technologies and low-emission industrial processes.
The project, which relies on the collaboration of universities, companies, and research institutions, aims to bring about a technological and economic revolution of great impact on the industry, by trialling projects on a world-first pilot furnace with unique features. This pilot facility, “The Global Centre of Excellence for Innovation”, R&D and Training will be located in St. Helens, United Kingdom.
Bormioli Pharma, committed for over 15 years in the search for concrete solutions to make plastic packaging more sustainable, confirms with this initiative the same responsibility also for glass, an infinitely recyclable material, but which still requires an important contribution in terms of reducing emissions. The agreement will give us privileged access to innovative technologies for glass production, strengthening our position and reducing our impact on the environment.
The decision to join Glass Futures is part of a broader program that the company has started years ago to increase the efficiency and sustainability of its products and business processes, from the research and development of solutions made from alternative sustainable sources, the use of recycled glass in production, up to the continuous updating of its technological platform, with a view to improving energy efficiency and reducing environmental impact.